Latest news
GSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Pharma - Margin Expansion Trends - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 16:23:57 GMTGSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Life Sciences - Earnings Expansion Phase - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 10:07:40 GMTGSK’s £400m Cambridge Research Centre Signals Renewed Confidence in UK Pharma Sector - Earnings Outlook Update - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 07:45:18 GMTGSK’s £400m Cambridge Research Centre Signals Renewed Confidence in UK Pharma Sector - EBITDA Estimate Trend - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 07:00:00 GMTGSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Pharma - Consensus Miss Rate - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 07:00:00 GMTGSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Life Sciences - Margin Expansion Trends - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 07:00:00 GMTGSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Pharma - Profit Recovery Report - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 19:33:17 GMTGSK’s £400m Cambridge R&D Centre Signals Renewed Confidence in UK Pharma - ROA Comparison - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 19:33:17 GMT